Risk factors for loss of residual renal function in children with end-stage renal disease undergoing automatic peritoneal dialysis.

Qian Shen, XiaoYan Fang, YiHui Zhai, Jia Rao, Jing Chen, QianFan Miao, YiNv Gong, MingHui Yu, Qing Zhou, Hong Xu
{"title":"Risk factors for loss of residual renal function in children with end-stage renal disease undergoing automatic peritoneal dialysis.","authors":"Qian Shen,&nbsp;XiaoYan Fang,&nbsp;YiHui Zhai,&nbsp;Jia Rao,&nbsp;Jing Chen,&nbsp;QianFan Miao,&nbsp;YiNv Gong,&nbsp;MingHui Yu,&nbsp;Qing Zhou,&nbsp;Hong Xu","doi":"10.1177/0896860819893818","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>This study analysed children with end-stage renal disease treated with automated peritoneal dialysis (APD) in our centre to explore the risk factors associated with residual renal function (RRF) loss.</p><p><strong>Methods: </strong>Children treated with APD as the initial renal replacement therapy regimen from January 2008 to December 2016 were included. All the children had a daily urine volume of ≥100 ml/m<sup>2</sup> when APD was initiated and a dialysis follow-up time of ≥12 months. A daily urine volume of <100 ml/m<sup>2</sup> after 12 months of APD treatment was defined as loss of RRF. Possible risk factors that may be associated with RRF loss were analysed.</p><p><strong>Results: </strong>A total of 66 children were included in the study. After 12 months of APD treatment, the daily urine volume decreased by 377.45 ± 348.80 ml/m<sup>2</sup>, the residual glomerular filtration rate decreased by 6.39 ± 3.69 ml/min/1.73 m<sup>2</sup> and 29 of the patients (43.9%) developed RRF loss. The higher risk of RRF loss after 1 year of APD treatment was most pronounced in patients with daily urine volume of ≤400 ml/m<sup>2</sup> before treatment, higher glucose exposure and higher ultrafiltration volume, while the lower risk of RRF loss was in patients with administration of diuretics. Each increase of 1 g/m<sup>2</sup>/day glucose exposure was associated with a 5% increase in RRF loss (odds ratio (OR) 1.05, <i>p</i> = 0.023) and each increase of 1 ml/m<sup>2</sup>/day ultrafiltration volume was associated with a 1% increase in RRF loss (OR 1.01, <i>p</i> = 0.013).</p><p><strong>Conclusion: </strong>In children undergoing APD, the risk for loss of RRF is associated with low urine volume at the start of APD, high glucose loading and high peritoneal ultrafiltration volume, while preservation of RRF is associated with the usage of diuretics.</p>","PeriodicalId":519220,"journal":{"name":"Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis","volume":" ","pages":"368-376"},"PeriodicalIF":0.0000,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/0896860819893818","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/0896860819893818","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/17 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: This study analysed children with end-stage renal disease treated with automated peritoneal dialysis (APD) in our centre to explore the risk factors associated with residual renal function (RRF) loss.

Methods: Children treated with APD as the initial renal replacement therapy regimen from January 2008 to December 2016 were included. All the children had a daily urine volume of ≥100 ml/m2 when APD was initiated and a dialysis follow-up time of ≥12 months. A daily urine volume of <100 ml/m2 after 12 months of APD treatment was defined as loss of RRF. Possible risk factors that may be associated with RRF loss were analysed.

Results: A total of 66 children were included in the study. After 12 months of APD treatment, the daily urine volume decreased by 377.45 ± 348.80 ml/m2, the residual glomerular filtration rate decreased by 6.39 ± 3.69 ml/min/1.73 m2 and 29 of the patients (43.9%) developed RRF loss. The higher risk of RRF loss after 1 year of APD treatment was most pronounced in patients with daily urine volume of ≤400 ml/m2 before treatment, higher glucose exposure and higher ultrafiltration volume, while the lower risk of RRF loss was in patients with administration of diuretics. Each increase of 1 g/m2/day glucose exposure was associated with a 5% increase in RRF loss (odds ratio (OR) 1.05, p = 0.023) and each increase of 1 ml/m2/day ultrafiltration volume was associated with a 1% increase in RRF loss (OR 1.01, p = 0.013).

Conclusion: In children undergoing APD, the risk for loss of RRF is associated with low urine volume at the start of APD, high glucose loading and high peritoneal ultrafiltration volume, while preservation of RRF is associated with the usage of diuretics.

终末期肾病儿童接受自动腹膜透析后残余肾功能丧失的危险因素
背景:本研究分析了在本中心接受自动腹膜透析(APD)治疗的终末期肾病患儿,以探讨与残余肾功能(RRF)丧失相关的危险因素。方法:纳入2008年1月至2016年12月以APD作为初始肾脏替代治疗方案的儿童。APD开始时,所有患儿的日尿量≥100 ml/m2,透析随访时间≥12个月。APD治疗12个月后,每日尿量为2则定义为RRF丧失。分析了可能与RRF丧失相关的风险因素。结果:本研究共纳入66名儿童。APD治疗12个月后,患者日尿量下降377.45±348.80 ml/m2,肾小球残余滤过率下降6.39±3.69 ml/min/1.73 m2, 29例(43.9%)患者出现RRF丢失。APD治疗1年后RRF丢失风险较高的患者,治疗前每日尿量≤400 ml/m2、葡萄糖暴露量较高、超滤量较高的患者最为明显,而使用利尿剂的患者RRF丢失风险较低。每增加1 g/m2/天葡萄糖暴露与RRF损失增加5%相关(比值比(OR) 1.05, p = 0.023),每增加1 ml/m2/天超滤体积与RRF损失增加1%相关(OR 1.01, p = 0.013)。结论:在APD患儿中,RRF丢失的风险与APD开始时的低尿量、高葡萄糖负荷和高腹膜超滤量有关,而RRF的保存与利尿剂的使用有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信